Cover Image

Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa

Human immunodeficiency virus (HIV)-exposed infants may be at increased risk of vaccine-preventable disease. This study was conducted as a post-licensure commitment in this population to evaluate the primary series, antibody persistence, and booster response to a licensed fully liquid hexavalent vacc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anthonet Koen (Author), Shabir Madhi (Author), Olga Lyabis (Author), Emmanuel Vidor (Author), Beverley Cowper (Author), Thinus Marais (Author), Dhaval Patel (Author), Claire Vigne (Author)
Format:	Book
Published:	Taylor & Francis Group, 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children
by: Sabelle Jallow, et al.
Published: (2017)

Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa
by: Michelle J Groome, et al.
Published: (2014)

Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children
by: Nginache Nampota-Nkomba, et al.
Published: (2024)

Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration
by: Shabir A. Madhi, et al.
Published: (2019)

Co-trimoxazole for HIV-exposed uninfected infants
by: Ceri Evans, et al.
Published: (2017)

Surviving and Thriving-Shifting the Public Health Response to HIV-Exposed Uninfected Children: Report of the 3rd HIV-Exposed Uninfected Child Workshop
by: Amy L. Slogrove, et al.
Published: (2018)

Outcome of HIV-exposed uninfected children undergoing surgery
by: van Bogerijen Guido, et al.
Published: (2011)

Age-specific associations with dental caries in HIV-infected, exposed but uninfected and HIV-unexposed uninfected children in Nigeria
by: Paul Akhigbe, et al.
Published: (2022)

Growth patterns and their contributing factors among HIV‐exposed uninfected infants
by: Aminata Ndiaye, et al.
Published: (2021)

Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine：a phase I clinical trial
by: Zhi-Wei Wu, et al.
Published: (2021)

Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants
by: James A. Church, et al.
Published: (2017)

Developmental status of human immunodeficiency virus-exposed uninfected premature infants compared with premature infants who are human immunodeficiency virus unexposed and uninfected
by: Charne Cox, et al.
Published: (2020)

Risk factors for stunting in children who are HIV‐exposed and uninfected after Option B+ implementation in Malawi
by: Gabriela Toledo, et al.
Published: (2023)

Immunogenicity of a combined schedule of trivalent oral and inactivated polio vaccines in South African infants
by: Shelina Moonsamy, et al.
Published: (2019)

Infectious disease morbidity and growth among young HIV-exposed uninfected children in Jamaica
by: Russell B. Pierre, et al.

A comparison of weight gain between HIV exposed uninfected and HIV unexposed uninfected infants who received KMC at Chris Hani Baragwanath Academic Hospital
by: Leshata Abigail Mapatha, et al.
Published: (2022)

Vaccination among HIV-infected, HIV-exposed uninfected and HIV-uninfected children: a systematic review and meta-analysis of evidence related to vaccine efficacy and effectiveness
by: Olatunji O. Adetokunboh, et al.
Published: (2019)

Estimates of the global population of children who are HIV-exposed and uninfected, 2000-18: a modelling study
by: Amy L Slogrove, PhD, et al.
Published: (2020)

Single priming and a booster dose of 10-valent and 13-valent pneumococcal conjugate vaccine (PCV) maintains suppression of vaccine serotype colonization in South African children at 3, 4, and 5 years of age: a single-centre, open-labelled, randomized trial
by: Courtney P. Olwagen, et al.
Published: (2024)

Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children
by: Nancy Birungi, et al.
Published: (2020)

Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya
by: Jillian Pintye, et al.
Published: (2015)

Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial
by: Zhi-Wei Wu, et al.
Published: (2023)

Statistical screening of hexavalent chromium biosorption by Sargassum
by: Abbas Rezaee, et al.
Published: (2014)

Hexavalent Chromium Adsorption onto Fire Clay
by: Ali Reza Rahmani, et al.
Published: (2016)

No Difference in Growth Outcomes up to 24 Months of Age by Duration of Exposure to Maternal Antiretroviral Therapy Among Children Who Are HIV-Exposed and Uninfected in Malawi
by: Gabriela Toledo, et al.
Published: (2022)

Cost minimization analysis of a hexavalent vaccine in Argentina
by: Ignacio Olivera, et al.
Published: (2023)

Feasibility of Brain Ultrasound Performed by Nurses in the Evaluation of Newborns Who Are HIV Exposed in Utero and Uninfected: A Pilot Study in Botswana
by: Hansel J. Otero, et al.
Published: (2024)

Does infant feeding method influence the incidence and pattern of morbidities among human immunodeficiency virus-exposed uninfected nigerian infants?
by: Olusoga Babatunde Ogunfowora, et al.
Published: (2017)

Assessing environmental enteric dysfunction via multiplex assay and its relation to growth and development among HIV-exposed uninfected Tanzanian infants.
by: Jacqueline M Lauer, et al.
Published: (2023)

Purification Method of Industrial Waste Water with Hexavalent Chromium Removal
by: Sara Banafsheafshan, et al.
Published: (2016)

Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial
by: Shahin Lockman, MD, et al.
Published: (2017)

Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children
by: Penelope C. Rose, et al.
Published: (2022)

Longitudinal Follow-Up of Blood Telomere Length in HIV-Exposed Uninfected Children Having Received One Year of Lopinavir/Ritonavir or Lamivudine as Prophylaxis
by: Audrey Monnin, et al.
Published: (2021)

Selected science: an industry campaign to undermine an OSHA hexavalent chromium standard
by: Lurie Peter, et al.
Published: (2006)

A worldwide overview for hexavalent vaccines and a glimpse into Turkiye's perspective
by: Metehan Özen, et al.
Published: (2024)

Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers
by: Ahmet Soysal, et al.
Published: (2021)

Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial
by: Brodie Daniels, PhD, et al.
Published: (2019)

Normal Thymic Size and Low Rate of Infections in Human Donor Milk Fed HIV-Exposed Uninfected Infants from Birth to 18 Months of Age
by: Dorthe Lisbeth Jeppesen, et al.
Published: (2013)

Neutrophil Counts in Healthy South African Infants: Implications for Enrollment and Adverse Event Grading in Clinical Trials in an African Setting
by: Anthonet Koen, MBBCh, et al.
Published: (2019)

Progress in researches on pulmonary carcinogenicity of hexavalent chromium and its mechanism: a review
by: Rui-rui ZHU, et al.
Published: (2023)